围术期卒中对经导管主动脉瓣置换术后中期结局的影响
该研究纳入2011至2018年单中心1193例TAVR患者,分析围术期神经事件对中期结局的影响。结果显示神经事件发生率为4.3%,患者短期和中期死亡率显著增加,残疾严重程度是死亡风险因素。
要点
- TAVR相关神经事件发生率4.3%,其中致残性卒中2.7%。
- 神经事件患者30天、1年、3年死亡率均显著高于无事件者。
- 改良Rankin量表残疾严重程度是30天、1年、3年死亡的独立风险因素。
核心结论
- 卒中增加TAVR术后短期和中期死亡率。
- TAVR神经事件的风险预测有助于患者选择和改善结局。
研究设计与样本
- 回顾性队列研究,纳入2011至2018年匹兹堡大学医学中心所有TAVR患者共1193例。
主要发现
- 51例(4.3%)发生神经事件,其中致残性卒中32例(2.7%),非致残性卒中19例(1.6%),包括5例(0.4%)短暂性脑缺血发作。
- 神经事件患者较无事件者年龄更大(85.8±4.2岁 vs 81.5±7.9岁,P<.001),女性比例更高(68.6% vs 31.4%,P=.007)。
- 神经事件患者30天、1年、3年死亡率分别为15.7% vs 2.6%、29.4% vs 13.9%、47.1% vs 35.7%。
- 改良Rankin量表残疾严重程度是30天死亡(HR 5.8,P=.003)、1年死亡(HR 2.1,P<.001)和3年死亡(HR 1.8,P<.001)的风险因素。
- TAVR神经事件预测因素包括年龄(每岁OR 1.11,P=.001)、低体表面积(每m2 OR 0.22,P=.050)、手术时长(每分钟OR 1.01,P=.024)和血制品输注(OR 3.23,P=.002)。
临床怎么用
- TAVR术前应评估卒中风险,尤其高龄、低体表面积、预计手术时间长及需血制品输注者。
- 术后发生神经事件者需关注残疾程度,改良Rankin量表评分高提示死亡风险增加。
局限性
- 单中心回顾性研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Transcatheter aortic valve replacement (TAVR) has evolved as an alternative therapy to open aortic valve replacement in most patients with aortic stenosis. Stroke associated with TAVR can be a devastating complication in the short term; however, little is known regarding midterm outcomes. METHODS: All patients undergoing TAVR at the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania from 2011 to 2018 were included. Modified Rankin Scale values as a measurement of stroke-related disability were extracted for patients who had neurologic deficits. RESULTS: Neurologic events (NEs) developed in 51 (4.3%) of the 1193 patients during the study period (32 [2.7%] had disabling strokes; 19 [1.6%] had nondisabling strokes, including 5 [0.4%] transient ischemic attacks). Patients who had TAVR-related NEs were older (85.8 ± 4.2 years vs 81.5 ± 7.9 years; P < .001) and predominantly female (68.6% vs 31.4%; P = .007), but they were comparable in terms of The Society of Thoracic Surgeons predicted mortality score and vascular access. Patients with NEs had increased short term and midterm mortality (15.7% vs 2.6%, 29.4% vs 13.9%, and 47.1% vs 35.7% at 30 days, 1 year, and 3 years, respectively). Severity of disability, determined by the modified Rankin Scale, was a risk factor for 30-day mortality (HR, 5.8; P = .003), 1-year mortality (HR, 2.1; P < .001) and 3-year mortality (HR, 1.8; P < .001). Predictors of TAVR NEs were older age (odds ratio [OR] per year of age, 1.11; P = .001), low body surface area (OR per m2, 0.22; P = .050), procedural duration (OR per minute, 1.01; P = .024), and administration of blood products (OR, 3.23; P = .002). CONCLUSIONS: Stroke increases short-term and midterm mortality after TAVR. Risk prediction for neurologic events in TAVR could aid the framework for patient selection and further improve outcomes.
引用
- Habertheuer A, Gleason TG, Kilic A, et al. Impact of Perioperative Stroke on Midterm Outcomes After Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2020. PMID: 32151578. doi:10.1016/j.athoracsur.2020.01.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。